Research article · 26 Jan 2026
Research articlePublished 30 Nov 2021
Efficacy of Adenosine vs. Verapamil For Management of Supraventricular Tachycardia Post-Coronary Artery Bypass Grafting: A Randomized Trial
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The aim is to compare the use of adenosine and verapamil for management of postoperative supraventricular tachycardia in terms of time of conversion of SVT to normal sinus rhythm, success rate, hospital stay length and adverse events Methods: Patients (54–65 years old) received adenosine or verapamil groups. In the adenosine group, patients received IV adenosine 6 mg bolus then wait 2 minutes, if it failed another 12 mg IV of adenosine was administered. In the verapamil group, patients received IV verapamil 5 mg bolus slowly over 2 minutes followed by a second IV bolus of 10 mg, 30 minutes after the initial dose in persistent Supra Ventricular Tachycardia (SVT). If SVT persisted, the patient was shifted to adenosine. Results: Patients were followed up regarding the efficacy of drug; blood pressure, mean time of conversion of SVT (time elapsed from effective dose of the study drug till conversion of SVT to sinus rhythm) and incidence of adverse events were recorded. The efficacy of adenosine was significantly higher than verapamil (P<0.001). The time of conversion of SVT to sinus rhythm was significantly shorter in adenosine group compared with verapamil group (P<0.001). The incidence of hypotension was comparable between the study groups. The mean arterial blood pressure and the incidence of complications were comparable. Conclusion: Intravenous administration of adenosine effectively treat SVT in terms of higher efficacy and shorter time of conversion of SVT to normal sinus rhythm compared with verapamil without any significant difference regarding the incidence of side effects between the study groups. Trial registration: This study was approved by Medical ethics committee of Ain Shams University approval number FMASU R 62/2019) and the protocol was prospectively registered at ClinicalTrials.gov: NCT 04203368 on December 16, 2019.
Subjects
Anaesthesia & PainAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Anesthesia & Clinical Research.
Research article · 22 Jul 2025
Preventive Strategies of Suxamethonium-Induced Fasciculation and Myalgia: A Review of Article and Guideline
Commentary · 16 Apr 2025
Adjuncts to Caudal Anesthesia for Prolonging Analgesic Duration
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnesthesia & Clinical Research
- SubjectAnaesthesia & Pain
- BylineArticles whose byline prints “Hoda Shokri”
- BylineArticles whose byline prints “Ihab Ali”